AKBA logo

Akebia Therapeutics, Inc. (AKBA) Gross Profit

Annual Gross Profit:

$91.34M-$27.55M(-23.17%)
December 31, 2024

Summary

  • As of today, AKBA annual gross profit is $91.34 million, with the most recent change of -$27.55 million (-23.17%) on December 31, 2024.
  • During the last 3 years, AKBA annual gross profit has risen by +$32.29 million (+54.68%).
  • AKBA annual gross profit is now -55.50% below its all-time high of $205.26 million, reached on December 31, 2022.

Performance

AKBA Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAincome statement metrics

Quarterly Gross Profit:

$49.06M-$3.17M(-6.07%)
September 30, 2025

Summary

  • As of today, AKBA quarterly gross profit is $49.06 million, with the most recent change of -$3.17 million (-6.07%) on September 30, 2025.
  • Over the past year, AKBA quarterly gross profit has increased by +$26.16 million (+114.22%).
  • AKBA quarterly gross profit is now -54.29% below its all-time high of $107.35 million, reached on June 30, 2022.

Performance

AKBA Quarterly Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAincome statement metrics

TTM Gross Profit:

$172.30M+$26.16M(+17.90%)
September 30, 2025

Summary

  • As of today, AKBA TTM gross profit is $172.30 million, with the most recent change of +$26.16 million (+17.90%) on September 30, 2025.
  • Over the past year, AKBA TTM gross profit has increased by +$65.42 million (+61.21%).
  • AKBA TTM gross profit is now -18.35% below its all-time high of $211.02 million, reached on September 30, 2019.

Performance

AKBA TTM Gross Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAincome statement metrics

Gross Profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

AKBA Gross Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-23.2%+114.2%+61.2%
3Y3 Years+54.7%+389.7%+9.8%
5Y5 Years-51.8%+68.4%+13.9%

AKBA Gross Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-55.5%+54.7%-6.1%>+9999.0%at high+152.9%
5Y5-Year-55.5%+54.7%-54.3%+795.9%-7.0%+339.7%
All-TimeAll-Time-55.5%>+9999.0%-54.3%+795.9%-18.4%>+9999.0%

AKBA Gross Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
$49.06M(-6.1%)
$172.30M(+17.9%)
Jun 2025
-
$52.24M(+5.7%)
$146.14M(+21.7%)
Mar 2025
-
$49.40M(+128.7%)
$120.10M(+31.5%)
Dec 2024
$91.34M(-23.2%)
$21.60M(-5.7%)
$91.34M(-14.5%)
Sep 2024
-
$22.90M(-12.6%)
$106.88M(-0.7%)
Jun 2024
-
$26.20M(+27.0%)
$107.62M(-10.4%)
Mar 2024
-
$20.64M(-44.4%)
$120.11M(+1.0%)
Dec 2023
$118.89M(-42.1%)
$37.14M(+57.1%)
$118.89M(+45.4%)
Sep 2023
-
$23.64M(-38.9%)
$81.75M(+20.0%)
Jun 2023
-
$38.70M(+99.3%)
$68.13M(-50.2%)
Mar 2023
-
$19.42M(>+9900.0%)
$136.79M(-7.1%)
Dec 2022
$205.26M(+247.6%)
$0.00(-100.0%)
$147.31M(-6.1%)
Sep 2022
-
$10.02M(-90.7%)
$156.91M(-15.3%)
Jun 2022
-
$107.35M(+258.6%)
$185.23M(+138.1%)
Mar 2022
-
$29.94M(+211.6%)
$77.80M(+19.6%)
Dec 2021
$59.05M(-47.7%)
$9.61M(-74.9%)
$65.05M(+34.4%)
Sep 2021
-
$38.34M(>+9900.0%)
$48.39M(+23.5%)
Jun 2021
-
-$81.00K(-100.5%)
$39.18M(-43.9%)
Mar 2021
-
$17.18M(+343.7%)
$69.80M(-38.2%)
Dec 2020
$112.85M(-40.5%)
-$7.05M(-124.2%)
$112.85M(-25.4%)
Sep 2020
-
$29.13M(-4.6%)
$151.28M(-14.0%)
Jun 2020
-
$30.53M(-49.3%)
$175.87M(-16.2%)
Mar 2020
-
$60.24M(+92.0%)
$209.77M(+10.1%)
Dec 2019
$189.65M(-4.7%)
$31.38M(-41.6%)
$190.50M(-9.7%)
Sep 2019
-
$53.71M(-16.6%)
$211.02M(+34.1%)
Jun 2019
-
$64.43M(+57.3%)
$157.31M(+69.4%)
Mar 2019
-
$40.97M(-21.1%)
$92.87M(+78.9%)
DateAnnualQuarterlyTTM
Dec 2018
$199.07M(+10.2%)
$51.90M(>+9900.0%)
$51.90M(-42.6%)
Sep 2018
-
$0.00(0.0%)
$90.36M(0.0%)
Jun 2018
-
$0.00(0.0%)
$90.36M(0.0%)
Mar 2018
-
$0.00(-100.0%)
$90.36M(0.0%)
Dec 2017
$180.61M(>+9900.0%)
$90.36M(>+9900.0%)
$90.36M(>+9900.0%)
Sep 2017
-
$0.00(0.0%)
$0.00(+100.0%)
Jun 2017
-
$0.00(0.0%)
-$94.00K(+32.9%)
Mar 2017
-
$0.00(0.0%)
-$140.00K(+18.6%)
Dec 2016
$0.00(+100.0%)
$0.00(+100.0%)
-$172.00K(+6.0%)
Sep 2016
-
-$94.00K(-104.3%)
-$183.00K(-47.6%)
Jun 2016
-
-$46.00K(-43.8%)
-$124.00K(-12.7%)
Mar 2016
-
-$32.00K(-190.9%)
-$110.00K(-13.8%)
Dec 2015
-$96.00K(-95.9%)
-$11.00K(+68.6%)
-$96.70K(+4.6%)
Sep 2015
-
-$35.00K(-9.4%)
-$101.40K(-27.4%)
Jun 2015
-
-$32.00K(-71.1%)
-$79.60K(-33.6%)
Mar 2015
-
-$18.70K(-19.1%)
-$59.60K(-21.6%)
Dec 2014
-$49.00K(-3669.2%)
-$15.70K(-18.9%)
-$49.00K(-41.6%)
Sep 2014
-
-$13.20K(-10.0%)
-$34.60K(-61.7%)
Jun 2014
-
-$12.00K(-48.1%)
-$21.40K(-127.7%)
Mar 2014
-
-$8100.00(-523.1%)
-$9400.00(-623.1%)
Dec 2013
-$1300.00(>-9900.0%)
-$1300.00(>-9900.0%)
-$1300.00(>-9900.0%)
Sep 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2012
$0.00(+100.0%)
-
-
Dec 2012
-
$0.00
$0.00
Dec 2011
-$39.20K
-
-

FAQ

  • What is Akebia Therapeutics, Inc. annual gross profit?
  • What is the all-time high annual gross profit for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. annual gross profit year-on-year change?
  • What is Akebia Therapeutics, Inc. quarterly gross profit?
  • What is the all-time high quarterly gross profit for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. quarterly gross profit year-on-year change?
  • What is Akebia Therapeutics, Inc. TTM gross profit?
  • What is the all-time high TTM gross profit for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. TTM gross profit year-on-year change?

What is Akebia Therapeutics, Inc. annual gross profit?

The current annual gross profit of AKBA is $91.34M

What is the all-time high annual gross profit for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high annual gross profit is $205.26M

What is Akebia Therapeutics, Inc. annual gross profit year-on-year change?

Over the past year, AKBA annual gross profit has changed by -$27.55M (-23.17%)

What is Akebia Therapeutics, Inc. quarterly gross profit?

The current quarterly gross profit of AKBA is $49.06M

What is the all-time high quarterly gross profit for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high quarterly gross profit is $107.35M

What is Akebia Therapeutics, Inc. quarterly gross profit year-on-year change?

Over the past year, AKBA quarterly gross profit has changed by +$26.16M (+114.22%)

What is Akebia Therapeutics, Inc. TTM gross profit?

The current TTM gross profit of AKBA is $172.30M

What is the all-time high TTM gross profit for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high TTM gross profit is $211.02M

What is Akebia Therapeutics, Inc. TTM gross profit year-on-year change?

Over the past year, AKBA TTM gross profit has changed by +$65.42M (+61.21%)
On this page